基本介紹
- 中文名：陶攀
- 學位/學歷：博士
- 職業：教師
- 專業方向：動物傳染病的致病機制、防控技術及產品研發
- 任職院校：華中農業大學動物科學技術學院動物醫學院
個人經歷,學術成果,
個人經歷
教育經歷
2000.09-2004.06 華中農業大學，動物科學專業，農學學士
2004.09-2009.06 武漢大學，微生物學專業，理學博士
工作經歷
2009-2015 美國天主教大學，博後
2015-2019 美國天主教大學，研究助理教授
2019-至今 華中農業大學，教授，博士生導師
研究方向
動物傳染病的致病機制、防控技術及產品研發。
學術成果
A著作類
1.Tao P, Li Q, Shivachandra SB, Rao VB*. Use of bacteriophage T4 as a nanoparticle platform to display and deliver pathogen antigens: construction of an effective anthrax vaccine. Methods Mol Biol. 2017; 1581:255-267.
2.Tao P, Mahalingam M, Rao VB*. Highly effective soluble and bacteriophage T4 nanoparticle plague vaccines against Yersinia pestis. Methods Mol Biol. 2016; 1403:499-518.
B論文類
1.Tao P, Mahalingam M, Zhu J, Moayeri M, Sha J, Lawrence WS, Leppla SH, Chopra AK, and Rao VB*. A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague. mBio. 2018, 9(5). pii: e01926-18. doi: 10.1128/mBio.01926-18.
2.Tao P*, Zhu J, Mahalingam M, Batra H, and Rao VB*. Bacteriophage T4 nanoparticles for vaccine delivery against infectious diseases. 2018, Adv. Drug Deliv. Rev. 2018, pii: S0169-409X (18) 30164-9. doi:10.1016 /j. addr.2018.06.025
3.Tao P, Wu X, and Rao VB*. Unexpected Evolutionary Benefit to Phages Imparted by Bacterial CRISPR-Cas9. 2018，Science Advances. 2018, 4 (2), eaar4134
4.Tao P, Mahalingam M, Zhu J, Moayeri M, Kirtley ML, Fitts EC, Andersson JA, Lawrence WS, Leppla SH, Chopra AK, Rao VB*. A Bivalent Anthrax–Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, Bacillus anthracis and Yersinia pestis. Front Immunol. 2017 8:687. doi: 10.3389/fimmu.2017. 00687. eCollection 2017.
5.Tao P*, Wu X, Tang W, Zhu J, Rao VB*. Engineering of Bacteriophage T4 Genome Using CRISPR-Cas9. ACS Synth Biol. 2017. doi: 10.1021/acssynbio.7b00179. Rao VB *,
6.Dai L, Li Z, Tao P*.Evolutionary Analysis of Tembusu Virus: Evidence for the Emergence of a Dominant Genotype. Infect Genet Evol. 2015, 32: 124-19.
7.Tao P, Mahalingam M, Marasa BS, Zhang Z, Chopra AK, Rao VB*. In vitro and in vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machine. PNAS. 2013, 110(15):5846-5851
8.Tao P, Mahalingam M, Kirtley ML, van Lier CJ, Sha J, Yeager LA, Chopra AK, Rao VB*. Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines. PLoS Pathog. 2013, 9(7):e1003495.
9.Rao VB*, Tao P, Mahalingam M, Marasa BS, Zhang Z, and Chopra AK. Delivery of vaccine genes and proteins into dendritic cells using the bacteriophage T4 DNA packaging machine (P3273). Journal of Immunology. 2013, 190:192.22.
10.Tao P, Luo M, Pan R, Ling D, Zhou S, Tien P and Pan Z*. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with a MHC class I-restricted epitope of nucleoprotein in mice. Antiviral Res. 2009, 81(3):253-60.
11.Tao P#, Luo M#, Zhu D, Qu S, Yang Z, Gao M, Guo D, Pan Z*. Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice. Viral immunology. 2009, 22(4):273-281.
Tao P, Dai L, Luo M, Tang F, Tien P, Pan Z*. Analysis of synonymous codon usage in classical swine fever virus. Virus genes. 2009, 38 (1):104-112.
科研項目
1.國家自然科學基金面上項目（主持）
2.華中農業大學高層人才啟動基金（主持）
